Abstract
Rationale Coronavirus disease 2019 (COVID-19) can cause a viral pneumonia together with other extrapulmonary complications. Acute cardiac related injury (ACRI) is common in hospitalized COVID-19 patients.
Objective To explain the pathological mechanism of ACRI and improve the treatment strategy by retrospectively observing the factors associated with ACRI and factors affecting the prognosis of ACRI with COVID-19 at an early stage.
Methods 619 COVID-19 patients were from Tongji Hospital, Wuhan. Student’s t test was used for continuous variables while Pearson χ2 test for categorical factors. Univariable and multivariable logistic regression models were applied to estimate odds ratio (OR) with 95% confidence interval (CI).
Results Among the 619 OOS Level-I hospitalized COVID-19 patients, 102 (16.5%) were defined as ACRI (stage-1: 59 cases, stage-2: 43 cases). 50% of ACRI patients developed into severe cases and 25 patients died(CFR=24.5%), 42 times that of non-ACRI patients. Elderly (OR=2.83, P<0.001), HTN (OR=2.09, P=0.005), γ-globulin (OR=2.08, P=0.004), TCM (OR=0.55, P=0.017), PLT (OR=2.94, P<0.001) and NLR (OR=2.20, P=0.004) were independently correlated with ACRI. SBP ⩾ 140, dyspnea, DM, smoking history were correlated with ACRI-stage2 only. In the prognostic subgroup analysis of ACRI patients, γ-globulin treatment could prolong LOS (29.0 ± 7.2 days Vs 23.5 ± 8.1 days, P=0.004). TCM (OR=0.26, P=0.006), SBP ⩾ 160 (OR= 22.70, P=0.005), male (OR=2.66, P=0.044) were associated with severe illness while corticosteroids treatment (OR=3.34, P=0.033) and male (OR=4.303, P=0.008) with death. Surprisingly, we found the mortality of non-elderly patients is higher than elderly (32.4% VS 20.0%, P=0.164), and both IKF and RASI treatment were not correlated with any prognostic indicators including severe, death and LOS.
Conclusion This study observed that several non-traditional issues were associated with early cardiac injury in COVID-19 while many traditional cardiovascular risk factors were not. Besides elderly and male, hypertension was confirmed to be the most important risk factor.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was supported by COVID-19 Emergency Response Project of Wuhan Science and Technology Department (2020020201010018).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of Tongji Hospital, Wuhan, China, approved this retrospective study and written informed consent was waived (No. TJ-C20200140).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The raw data was extracted from electronic medical records with standardized data collection forms in Tongji Hospital (Wuhan, China), which had been approved by the Research Ethics Commission of Tongji Hospital, Tongji medical college of HUST. The data used to support the findings of this study are available from the corresponding author upon request.
Nonstandard Abbreviations and Acronyms
- ACI
- Acute cardiac injury
- ACRI
- Acute cardiac related injury
- AMI
- Acute myocardial injury
- CFR
- Case-fatality rate
- CHD
- Coronary heart disease
- COVID-19
- Coronavirus disease-2019
- CRP
- C-reactive protein
- cTnI
- Cardiac troponin I
- CVD
- Cardiovascular disease
- DD
- D-Dimer
- DM
- Diabetes mellitus
- eGFR
- Estimated glomerular filtration rate
- HSBP
- High systolic blood pressure
- IKF
- Impaired kidney function
- IL-6
- Interleukin 6
- IVIG
- Intravenous immunoglobulin
- LDH
- Lactate dehydrogenase
- LOS
- Length of stay
- MAP
- Mean arterial pressure
- NEU
- Neutrophil
- NT-proBNP
- N-terminal pro-brain natriuretic peptide
- NLR
- Neutrophil lymphocyte ratio
- OOS
- Oximeter oxygen saturation
- RAS
- Renin-angiotensin-aldosterone system
- RASI
- Renin-angiotensin-aldosterone system inhibitors
- Scr
- Serum creatinine
- WHO
- World Health Organization
